about
Mass spectrometric behavior of anabolic androgenic steroids using gas chromatography coupled to atmospheric pressure chemical ionization source. Part I: ionization.Metabolomics analysis identifies different metabotypes of asthma severity.LC-MS/MS detection of unaltered glucuronoconjugated metabolites of metandienone.Renal denervation attenuates hypertension and renal dysfunction in a model of cardiovascular and renal disease, which is associated with reduced NADPH and xanthine oxidase activity.A new sulphate metabolite as a long-term marker of metandienone misuse.Aronia-citrus juice (polyphenol-rich juice) intake and elite triathlon training: a lipidomic approach using representative oxylipins in urine.Leukotriene E4 induces airflow obstruction and mast cell activation via the CysLT1 receptor.Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.Lipid Mediator Quantification in Isolated Human and Guinea Pig Airways: An Expanded Approach for Respiratory ResearchMass spectrometric characterization of urinary toremifene metabolites for doping control analysesNew potential markers for the detection of boldenone misuseDetection and characterization of urinary metabolites of boldione by LC-MS/MS. Part II: Conjugates with cysteine and N-acetylcysteineAlternative long-term markers for the detection of methyltestosterone misusePseudoephedrine and circadian rhythm interaction on neuromuscular performanceExhaled volatile organic compounds as markers for medication use in asthmaExosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1Quantitative metabolic profiling of urinary eicosanoids for clinical phenotypingDetection and characterization of urinary metabolites of boldione by LC-MS/MS. Part I: Phase I metabolites excreted free, as glucuronide and sulfate conjugates, and released after alkaline treatment of the urine
P50
Q33461874-B9AEBE06-8511-4D20-987E-C77C26BA1357Q33587291-E36992F1-3809-4931-B273-282C3EAC8EA4Q39727848-78092D00-9BA0-4F46-97CD-3E95B185883AQ41084517-79A8E61A-884D-4289-BE49-D9AFF08E787EQ44916211-B3C728BF-A18A-4645-8941-E1B5B0E6E536Q49907509-8707FA8A-F92B-4B02-B1C3-9F8A4204533AQ52727846-A4EF8786-037B-43C1-8014-5E369D2C15ABQ54198922-F074048A-73FD-45F0-AD11-7F6AB46EFA84Q57095445-AED48D90-396C-47CE-A427-E64018C72E1BQ59260548-1D7374FC-8DE0-47CC-A656-7930C7F86D21Q84289789-EAA114EF-9EAB-4ADC-A313-3AB398B0DFF6Q85268262-CE9BFE77-AD81-4FD3-9CC3-027AB331481DQ85364365-9B8A3F63-6F0E-4DFB-A4B6-6A33253955D1Q86310533-ABE7A9D3-6CE5-4E61-8AD1-6A3E6D482B8FQ90083700-55D9B34F-816E-47B2-92FB-4D51A3015624Q90217507-13F1336D-0B87-4A4A-8487-A6D40F311C57Q92177229-9370942D-6640-46DE-A015-F0A3450A8BADQ95446736-986AD2C2-041E-455E-8FDD-3E30EFC1E0DB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristina Gómez
@ast
Cristina Gómez
@en
Cristina Gómez
@es
Cristina Gómez
@nl
type
label
Cristina Gómez
@ast
Cristina Gómez
@en
Cristina Gómez
@es
Cristina Gómez
@nl
prefLabel
Cristina Gómez
@ast
Cristina Gómez
@en
Cristina Gómez
@es
Cristina Gómez
@nl
P106
P21
P31
P496
0000-0001-8518-0095